LivaNova PLC (NASDAQ:LIVN) Downgraded by BidaskClub to Buy

BidaskClub lowered shares of LivaNova PLC (NASDAQ:LIVN) from a strong-buy rating to a buy rating in a research report report published on Monday, July 24th.

Shares of LivaNova PLC (LIVN) traded down 0.66% during trading on Monday, reaching $61.78. The company had a trading volume of 347,553 shares. LivaNova PLC has a 1-year low of $40.83 and a 1-year high of $64.95. The stock has a market capitalization of $3.02 billion, a price-to-earnings ratio of 110.32 and a beta of 0.62. The company’s 50 day moving average is $61.64 and its 200-day moving average is $55.08.

LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings results on Wednesday, August 9th. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.82 by $0.19. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. The company had revenue of $321.40 million for the quarter, compared to analyst estimates of $315.75 million. LivaNova PLC’s revenue was up .1% on a year-over-year basis. On average, equities research analysts anticipate that LivaNova PLC will post $3.16 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “LivaNova PLC (NASDAQ:LIVN) Downgraded by BidaskClub to Buy” was originally posted by Stock Observer and is owned by of Stock Observer. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.thestockobserver.com/2017/08/12/livanova-plc-nasdaqlivn-downgraded-by-bidaskclub-to-buy-updated-updated.html.

In other LivaNova PLC news, Director Sharon O’kane purchased 1,000 shares of the stock in a transaction on Tuesday, May 23rd. The shares were bought at an average cost of $58.58 per share, with a total value of $58,580.00. Following the completion of the acquisition, the director now owns 1,000 shares in the company, valued at $58,580. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Over the last ninety days, insiders sold 3,000 shares of company stock worth $180,840. 0.28% of the stock is owned by corporate insiders.

Large investors have recently bought and sold shares of the company. Usca Ria LLC purchased a new stake in LivaNova PLC during the first quarter valued at about $415,000. Oregon Public Employees Retirement Fund raised its stake in LivaNova PLC by 1.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 15,360 shares of the company’s stock valued at $753,000 after buying an additional 200 shares during the last quarter. Investment Counselors of Maryland LLC purchased a new stake in LivaNova PLC during the first quarter valued at about $4,630,000. Janney Montgomery Scott LLC raised its stake in LivaNova PLC by 30.6% in the first quarter. Janney Montgomery Scott LLC now owns 11,144 shares of the company’s stock valued at $546,000 after buying an additional 2,614 shares during the last quarter. Finally, Glen Harbor Capital Management LLC raised its stake in LivaNova PLC by 11.4% in the first quarter. Glen Harbor Capital Management LLC now owns 2,992 shares of the company’s stock valued at $147,000 after buying an additional 306 shares during the last quarter. 73.41% of the stock is currently owned by institutional investors and hedge funds.

LivaNova PLC Company Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply